Clinical Programs Pipeline Innovation Engine Clinical Trials at Biohaven Publications Kv7 TRPM3 TYK2/JAK1 GLUTAMATE MYOSTATIN CD-38 EXPLORE OUR PROGRAMS Biohaven has built and continues to advance clinical programs that include late- and early-stage products. Our goal is to continue to study and seek regulatory approvals for each of these molecules. Kv7 TRPM3 TYK2/JAK1 GLUTAMATE MYOSTATIN CD-38